Skip to main content

Together we are beating cancer

Donate now

Search Results: BRCA

Showing 12 out of 265 results
Headshots of Ruth Plummer, Eve Wiltshaw and Judith Bliss

As our 20th anniversary year draws to a close, we're celebrating some of the pioneering women who have contributed to impactful cancer research and paved the way for even more. As our 20th anniversary year draws to a close, we're celebrating some of the pioneering women who have contributed to impactful cancer research and paved the way for even more.

by Amy Warnock | In depth | 18 January 2023

18 January 2023

Black in Cancer co-founders Dr Henry Henderson and Sigourney Bonner on stage at the start of teh Black in Cancer conference

Many cancers affect Black people differently. Often, their outcomes are worse. There's a long way to go to change that, but this is how we can start. Many cancers affect Black people differently. Often, their outcomes are worse. There's a long way to go to change that, but this is how we can start.

by Tim Gunn | In depth | 31 October 2022

31 October 2022

As newly appointed chief scientist for Cancer Research UK, Professor KJ Patel brings a wealth of expertise and experience. As newly appointed chief scientist for Cancer Research UK, Professor KJ Patel brings a wealth of expertise and experience.

by Phil Prime | Interview | 12 October 2022

12 October 2022

A prostate cancer cell.

NICE does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective NICE does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective

by Jacob Smith | News | 13 September 2022

13 September 2022

We spoke to Professor Andrew Tutt about how you build a successful scientific team, the importance of translation and why you always need a touch of humbleness… We spoke to Professor Andrew Tutt about how you build a successful scientific team, the importance of translation and why you always need a touch of humbleness…

by Phil Prime | Interview | 10 April 2022

10 April 2022

The first episode features Ruth Plummer. Ruth is Professor of Experimental Cancer Medicine at Newcastle University and Director of the CRUK Newcastle Cancer Centre. She talks about how the DNA repair inhibition field has changed over 20 years, her instrumental role in the development of the PARP inhibitor Rucaparib and why work/life balance is so important for the future of research life. The first episode features Ruth Plummer. Ruth is Professor of Experimental Cancer Medicine at Newcastle University and Director of the CRUK Newcastle Cancer Centre. She talks about how the DNA repair inhibition field has changed over 20 years, her instrumental role in the development of the PARP inhibitor Rucaparib and why work/life balance is so important for the future of research life.

by Phil Prime | Podcast | 4 February 2022

4 February 2022

This entry is part 1 of 9 in the series Cancer Research Matters - series 1
Computational analysis of cancer

From a legacy of life-saving medicines to developing new tools to detect cancer, our scientists have been at the forefront of cancer research for 120 years. From a legacy of life-saving medicines to developing new tools to detect cancer, our scientists have been at the forefront of cancer research for 120 years.

by Katie Roberts | Analysis | 2 February 2022

2 February 2022

Breast cancer screening

Cancer Research UK-funded scientists are using innovative techniques to understand how resistance to a targeted cancer drug is unfolding. Cancer Research UK-funded scientists are using innovative techniques to understand how resistance to a targeted cancer drug is unfolding.

by Lilly Matson | Analysis | 10 January 2022

10 January 2022

Pioneering therapeutics targeting the damage repair mechanism of DNA polymerase theta in a range of cancers have entered human trials - we tell the story from discovery to translation. Pioneering therapeutics targeting the damage repair mechanism of DNA polymerase theta in a range of cancers have entered human trials - we tell the story from discovery to translation.

by Cancer Research UK | In depth | 5 November 2021

5 November 2021

prostate cancer biopsy
  • Science & Technology
  • Health & Medicine

Targeted prostate cancer screening: Are we there yet?

Prostate cancer screening is back in the news, as results from a targeted screening programme are released. But when it comes to yearly checks, are we there yet? Prostate cancer screening is back in the news, as results from a targeted screening programme are released. But when it comes to yearly checks, are we there yet?

by Katie Roberts | Analysis | 20 October 2021

20 October 2021